Monopar Therapeutics Statistics
Total Valuation
MNPR has a market cap or net worth of $206.94 million. The enterprise value is $149.05 million.
Important Dates
The next estimated earnings date is Friday, August 8, 2025, before market open.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MNPR has 6.12 million shares outstanding. The number of shares has increased by 62.90% in one year.
Current Share Class | 6.12M |
Shares Outstanding | 6.12M |
Shares Change (YoY) | +62.90% |
Shares Change (QoQ) | +42.52% |
Owned by Insiders (%) | 4.60% |
Owned by Institutions (%) | 29.09% |
Float | 2.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.77 |
P/TBV Ratio | 3.80 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.92
Current Ratio | 36.92 |
Quick Ratio | 36.56 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.27% and return on invested capital (ROIC) is -36.15%.
Return on Equity (ROE) | -54.27% |
Return on Assets (ROA) | -34.49% |
Return on Invested Capital (ROIC) | -36.15% |
Return on Capital Employed (ROCE) | -32.95% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.04M |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +720.31% in the last 52 weeks. The beta is 1.01, so MNPR's price volatility has been similar to the market average.
Beta (5Y) | 1.01 |
52-Week Price Change | +720.31% |
50-Day Moving Average | 37.14 |
200-Day Moving Average | 26.83 |
Relative Strength Index (RSI) | 46.40 |
Average Volume (20 Days) | 24,604 |
Short Selling Information
The latest short interest is 34,004, so 0.56% of the outstanding shares have been sold short.
Short Interest | 34,004 |
Short Previous Month | 38,031 |
Short % of Shares Out | 0.56% |
Short % of Float | 1.17% |
Short Ratio (days to cover) | 1.93 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.66M |
Pretax Income | -7.12M |
Net Income | -16.57M |
EBITDA | n/a |
EBIT | -17.66M |
Earnings Per Share (EPS) | -$3.50 |
Full Income Statement Balance Sheet
The company has $54.55 million in cash and n/a in debt, giving a net cash position of $54.55 million or $8.92 per share.
Cash & Cash Equivalents | 54.55M |
Total Debt | n/a |
Net Cash | 54.55M |
Net Cash Per Share | $8.92 |
Equity (Book Value) | 53.59M |
Book Value Per Share | 8.76 |
Working Capital | 53.58M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -10.41M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNPR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -62.90% |
Shareholder Yield | -62.90% |
Earnings Yield | -8.14% |
FCF Yield | n/a |
Analyst Forecast
The average price target for MNPR is $59.50, which is 75.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $59.50 |
Price Target Difference | 75.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.
Last Split Date | Aug 13, 2024 |
Split Type | Reverse |
Split Ratio | 0.2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |